At a meeting last week, the Senate Committee on Homeland Security and Government Affairs considered a bill that would "prohibit contracting with certain biotechnology providers," with four Chinese companies named.

You don't have access to this post on China Trade Monitor at the moment, but if you upgrade your account you'll be able to see the whole thing, as well as all the other posts in the archive! Subscribing only takes a few seconds and will give you immediate access.

This post is for subscribers only

Subscribe now
US CongressBiotechUS LegislationForeign Legislation